
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Polydextrose is a synthetic prebiotic fiber that promotes digestive health by selectively feeding beneficial gut bacteria. It works by resisting digestion in the small intestine and fermenting in the colon, producing short-chain fatty acids that support gut barrier function.

Reported Benefits (Provisional)
Origin & History

Polydextrose is a synthetic polymer of glucose, produced by the condensation of glucose with sorbitol and citric acid. It is primarily used as a low-calorie bulking agent and fiber supplement in food products.
Research Narrative (Provisional)
RCTs and observational studies have shown polydextrose's effectiveness in improving digestive health and aiding weight management. Its role as a prebiotic is supported by in vitro studies.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains approximately 1 kcal per gram. - Provides 90% soluble fiber. - Low in carbohydrates and sugars.
Reported Mechanism (Provisional)
Polydextrose resists hydrolysis by digestive enzymes in the small intestine due to its unique α-1,6-glycosidic bonds with random branching. Upon reaching the colon, beneficial bacteria like Bifidobacterium and Lactobacillus ferment polydextrose, producing short-chain fatty acids including acetate, propionate, and butyrate. These metabolites lower colonic pH, inhibit pathogenic bacteria growth, and strengthen intestinal barrier function through enhanced tight junction proteins.
Clinical Narrative (Provisional)
Multiple randomized controlled trials with 20-60 participants show polydextrose increases stool frequency by 20-30% and beneficial bacteria populations by 0.5-1.0 log units. A 12-week study of 178 adults found 8g daily polydextrose significantly improved bowel movement frequency and stool consistency compared to placebo. Smaller studies demonstrate increased fecal short-chain fatty acid concentrations, though larger long-term trials are needed to establish optimal dosing protocols. Evidence quality is moderate, with most studies lasting 2-12 weeks.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







